FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/07/035159 [Registered on: 27/07/2021] Trial Registered Prospectively
Last Modified On: 05/08/2021
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia
Preventive 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   Comparative evaluation of preoperative nebulization with two doses of budesonide for post operative sore throat following endotracheal intubation under general anaesthesia 
Scientific Title of Study   Comparative evaluation of preoperative nebulization with two doses of budesonide for post operative sore throat following endotracheal intubation under general anaesthesia 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Ankush Garg 
Designation  PG Resident 
Affiliation  Vardhaman Mahavir Medical College and Safdarjung Hospital 
Address  HOD Anaesthesia office, main OT Complex Ground floor,
Safdarjung Hospital, Ansari Nagar East
South
DELHI
110029
India 
Phone  01126161960  
Fax  01126163072  
Email  gargankush27@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Shruti Jain 
Designation  Consultant 
Affiliation  Vardhaman Mahavir Medical College and Safdarjung Hospital 
Address  HOD office Anaesthesia, Main OT complex ground floor
safdarjung Hospital, Ansari Nagar East
South
DELHI
110029
India 
Phone  9212308441  
Fax  01126163072  
Email  shruti.anaesth@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Shruti Jain 
Designation  Professor 
Affiliation  Vardhaman Mahavir Medical College and Safdarjung Hospital 
Address  Department of Anaesthesia and Intensive Care, HOD office, Ground floor Main OT Complex
safdarjung Hospital, Ansari Nagar East
South
DELHI
110029
India 
Phone  9212308441  
Fax  01126163072  
Email  Shruti.anaesth@gmail.com  
 
Source of Monetary or Material Support  
Self sponsored 
Vardhaman Mahavir Medical college and Safdarjung Hospital 
 
Primary Sponsor  
Name  Ankush Garg 
Address  Vardhaman Mahavir Medical College and Safdarjung Hospital, Ansari nagar East - 110029 
Type of Sponsor  Other [Self sponsored] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Ankush Garg  Vardhman Mahavir Medical College and Safdarjung Hospital  Department of Anaesthesia and Intensive Care, Safdarjung Hospital, Ansari Nagar East
South
DELHI 
9871281610

gargankush27@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee of Vardhman Mahavir Medical College and Safdarjung Hospital  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K802||Calculus of gallbladder without cholecystitis, (2) ICD-10 Condition: N859||Noninflammatory disorder of uterus, unspecified, (3) ICD-10 Condition: K353||Acute appendicitis with localizedperitonitis,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Budesonide  Preoperative Nebulisation with 250 micrograms of budesonide made to 5ml for 10 minutes, 10 minutes before induction 
Intervention  Budesonide  Preoperative nebulisation with 500 microgram of Budesonide made to 5ml for 10 minutes, 10 minutes before induction 
Comparator Agent  Normal Saline  Preoperative nebulisation with 5ml of Normal Saline for 10 minutes, 10 minutes before induction 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Belonging to American society of Anaesthesiologists (ASA) physical status I and II undergoing laparoscopic surgery under general anaesthesia with endotracheal intubation 
 
ExclusionCriteria 
Details  1)Patients with difficult airway
2)Patients with a history of pre-operative sore throat, oral surgeries, asthma, diabetes, chronic obstructive pulmonary disease, head and neck surgeries.
3)Patient with known allergies to study drug and rescue drugs.
4)Patients consuming non-steroidal anti-inflammatory drugs within 24 hours prior to the surgery or on systemic or topical steroid therapy or having taken steroid drugs within five days prior to the surgery.
5)Duration of surgery > 1 hour and < 4 hours. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
Incidence and severity of Postoperative sore throat  0, 6, 12, 24 hours after extubation 
 
Secondary Outcome  
Outcome  TimePoints 
Incidence of cough and hoarseness of voice  0, 6, 12, 24 hours after extubation 
 
Target Sample Size   Total Sample Size="105"
Sample Size from India="105" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Post Marketing Surveillance 
Date of First Enrollment (India)   29/07/2021 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   nil 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - All of the individual participant data collected during the trial, after de-identification.

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Informed Consent Form
    Response - Clinical Study Report
    Response -  Analytic Code

  3. Who will be able to view these files?
    Response - Anyone

  4. For what types of analyses will this data be available?
    Response - Any purpose.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [gargankush27@gmail.com].

  6. For how long will this data be available start date provided 15-09-2021 and end date provided 01-09-2022?
    Response - Immediately following publication. No end date.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary  

Post-operative sore throat (POST) is an unavoidable outcome of general anaesthesia following endotracheal intubation that affects up to 62% of patients undergoing general anaesthesia. It occurs because of aseptic inflammatory process caused by irritation of the pharyngeal mucosa during laryngoscopy and tracheal mucosa by cuff of endotracheal tube. It leads to patient’s distress and dissatisfaction. Complaints of patients include minor throat irritation, inability to swallow, hoarseness of voice and cough. In most cases it resolves spontaneously without specific treatment. However, in moderate to severe cases, it may require treatment for pain and dysphagia.

The aetiology of POST is multifactorial. It includes patient-related factors such as age, sex, smoking and intubation factors including time and manipulations needed to insert the tube, duration for which the tube is in place, tube size, intra-cuff pressure, cuff design, intraoperative tube movement and suctioning.

Various non-pharmacological and pharmacological methods have been used for attenuating POST with varying efficacy. The non-pharmacological methods include smaller size endotracheal tubes, lubricating the endotracheal tube with water soluble jelly, careful airway instrumentation, intubating after full relaxation, gentle oesophageal suctioning, minimizing intra-cuff pressure and extubation when the tracheal cuff is fully deflated. The pharmacological methods include pre-operative gargling and nebulization with various agents like ketamine, local anaesthetics, budesonide, beclomethasone and azulene sulphonate etc. Steroids are well known for their anti-inflammatory function. They are widely used in clinic. The inhaled corticosteroids (ICSs), like budesonide and fluticasone, are widely used for patients at risk of airway diseases (i.e., asthma, chronic obstructive pulmonary disease (COPD) and acute pharyngitis) due to its high efficacy in controlling and preventing symptom symptoms with reduced systemic side effects since it can be directly delivered to the airways without introducing a systemic exposure. The beneficial properties of ICS include low oral bioavailability, high systemic clearance, and sufficient receptor binding affinity. Since ICS inhalation possesses these beneficial properties, it has been considered a more secure treatment. Budesonide has been used in doses as high as 500 microgram given twice daily (1mg per day) through nebulized form for 10 consecutive days. It showed no hypothalamo-pituitary-adrenal-axis suppression. This proves the safety of the study drug.

Previous studies have reported different protocols in terms of number of times budesonide is administered, varying from a single preoperative dosage to multiple nebulisation

Total dose of budesonide used in these studies has varied from 200 microgram preoperatively to 1 milligram given in multiple divided doses, but it has been found that single pre-operative dosage is more efficacious than multiple nebulisation for preventing POST.

In this study we aim to compare the efficacy of pre-operative nebulisation with 250 microgram of budesonide versus 500 microgram and normal saline in reduction of incidence and severity of POST in adult patients following endotracheal intubation under general anaesthesia undergoing laproscopic surgery.

 
Close